Atomo Diagnostics Limited (ASX:AT1)
0.0180
+0.0010 (5.88%)
Sep 17, 2026, 3:55 PM AEST
Atomo Diagnostics Revenue
In the fiscal year ending June 30, 2026, Atomo Diagnostics had annual revenue of 5.33M AUD with 40.65% growth. Atomo Diagnostics had revenue of 3.15M in the half year ending June 30, 2026, with 45.78% growth.
Revenue
5.33M
Revenue Growth
+40.65%
P/S Ratio
2.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 5.33M | 1.54M | 40.65% |
| Jun 30, 2025 | 3.79M | -294.18K | -7.20% |
| Jun 30, 2024 | 4.09M | 1.54M | 60.65% |
| Jun 30, 2023 | 2.54M | -9.79M | -79.38% |
| Jun 30, 2022 | 12.34M | 5.62M | 83.69% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 34.87M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| CurveBeam AI | 8.67M |
| CONNEQT Health | 7.96M |
| OncoSil Medical | 5.09M |
| Control Bionics | 4.77M |
Atomo Diagnostics News
- 17 days ago - Atomo Diagnostics Annual report: H2 2026 - Filings
- 17 days ago - Atomo Diagnostics Slides: H2 2026 - Filings
- 7 weeks ago - Atomo Diagnostics Earnings Call Transcript: Q4 2026 - Transcripts
- 7 weeks ago - Atomo Diagnostics Slides: Q4 2026 - Filings
- 4 months ago - Atomo Diagnostics Earnings Call Transcript: Q3 2026 - Transcripts
- 4 months ago - Atomo Diagnostics Slides: Q3 2026 - Filings
- 6 months ago - Atomo Diagnostics Earnings Call Transcript: H1 2026 - Transcripts
- 6 months ago - Atomo Diagnostics Quarterly report: H1 2026 - Filings